» Articles » PMID: 15046654

Microvascular Decompression for Glossopharyngeal Neuralgia: Long-term Effectiveness and Complication Avoidance

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 2004 Mar 30
PMID 15046654
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To establish the long-term safety, efficacy, and durability of microvascular decompression (MVD) for the treatment of glossopharyngeal neuralgia, this study presents the immediate (<6 mo) postoperative and long-term results of a large series of 47 patients with treated with MVD.

Methods: Operative reports and hospital charts were analyzed to collect demographic information, clinical presentation, and surgical findings. Surgical results and complications were ascertained by direct patient contact or by contact with the patient's family or physician if the patient was dead. Long-term (>10 yr) personal follow-up was available for 29 of 47 patients.

Results: Forty-six (98%) of 47 patients experienced complete relief of pain immediately after MVD. Long-term follow-up was available for 29 of these 47 patients (range, 125-211 mo; median, 152 mo, or 12.7 yr), and 28 of these 29 patients continued to be pain-free. Permanent neurological deficits (>6 mo) attributed to the surgery were observed in 5 (11%) of 47 patients. Of these patients, 4 of 5 had mild hoarseness or dysphagia or both, and one had a Grade II/VI facial nerve paresis.

Conclusion: This study demonstrates that MVD is a safe, effective, and durable surgical procedure for producing prolonged pain relief in patients with medically intractable glossopharyngeal neuralgia.

Citing Articles

Concurrent glossopharyngeal neuralgia and oromandibular dystonia resolved after microvascular decompression of the trigeminal and glossopharyngeal nerve: A rare presentation.

Aldhafeeri W, Alanazi R, Abdullah J, Nazer A Surg Neurol Int. 2024; 15:132.

PMID: 38742011 PMC: 11090590. DOI: 10.25259/SNI_642_2023.


Comparative analysis of MVD and RHZ in the treatment of primary glossopharyngeal neuralgia: A clinical report on 61 cases.

Wang L, Liu Q, Dong X, Wang J Front Neurol. 2023; 14:1024142.

PMID: 36860578 PMC: 9968861. DOI: 10.3389/fneur.2023.1024142.


GLOSSOPHARYNGEAL NERVE AS A SOURCE OF OROFACIAL PAIN - DIAGNOSTIC AND THERAPEUTIC CHALLENGES.

Sklebar D, Vucemilo L, Sklebar T Acta Clin Croat. 2023; 61(Suppl 2):90-95.

PMID: 36824642 PMC: 9942470. DOI: 10.20471/acc.2022.61.s2.11.


Current advances in the surgical treatment of glossopharyngeal neuralgia.

Berckemeyer M, Suarez-Meade P, Carcelen M, Ricci M, Cheshire W, Trifiletti D Neurosurg Rev. 2023; 46(1):47.

PMID: 36725770 DOI: 10.1007/s10143-023-01948-y.


Glossopharyngeal Neuralgia.

Park J, Ahn Y J Korean Neurosurg Soc. 2022; 66(1):12-23.

PMID: 36480819 PMC: 9837485. DOI: 10.3340/jkns.2022.0178.